The risk of<unk> ent thrombosis is reduced with the use of combined antiplatelet therapy.
There are better outcomes noted with the use of aspirin plus ticlopidine or clopidogrel than with aspirin plus warfarin or aspirin alone.
Preliminary evidence suggests prasugrel resulted in fewer ischaemic outcomes including<unk> ent thrombosis than with<unk> andard clopidogrel.
Prevention of ST
Oral candidiasis prevention
Venous thromboembolism prevention
Chancroid prevention
Epistaxis primary prevention
Malaria prevention
Ascariasis prevention
Deep vein thrombosis prevention